(Q43639304)

25 November 2017

Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice (English)

1 reference

25 November 2017

0 references

multiple drug resistance

1 reference

1

1 reference

25 November 2017

C Rousselle

2

1 reference

PubMed ID

11405289

25 November 2017

C Dagenais

series ordinal

3

1 reference

PubMed ID

11405289

25 November 2017

J M Scherrmann

series ordinal

4

1 reference

25 November 2017

1 February 2001

1 reference

25 November 2017

Pharmaceutical Research

1 reference

25 November 2017

18

1 reference

25 November 2017

183-190

1 reference

25 November 2017

2

1 reference

Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein

25 November 2017

1 reference

12 December 2020

Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

1 reference

12 December 2020

New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

1 reference

12 December 2020

In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

1 reference

12 December 2020

Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.

1 reference

12 December 2020

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

1 reference

12 December 2020

Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine

1 reference

12 December 2020

Comparative pharmacokinetics of vinblastine after a 96-hour continuous infusion in wild-type mice and mice lacking mdr1a P-glycoprotein.

1 reference

12 December 2020

The blood-brain barrier. I. Morphologic data

1 reference

12 December 2020

Two transport binding sites of P-glycoprotein are unequal yet contingent: initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependence

1 reference

12 December 2020

Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo

1 reference

12 December 2020

In vitro models of the blood-brain barrier.

1 reference

12 December 2020

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

12 December 2020

Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats

1 reference

12 December 2020

Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.

1 reference

12 December 2020

P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity

1 reference

12 December 2020

Clinical studies with modulators of multidrug resistance.

1 reference

12 December 2020

An in situ brain perfusion technique to study cerebrovascular transport in the rat.

1 reference

12 December 2020

Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice

1 reference

12 December 2020

Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.

1 reference

12 December 2020

Interaction of drugs with P-glycoprotein in brain capillaries

1 reference

12 December 2020

Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells.

1 reference

12 December 2020

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

12 December 2020

The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice.

1 reference

12 December 2020

Morphine antinociception is enhanced in mdr1a gene-deficient mice

1 reference

12 December 2020

Identification of members of the P-glycoprotein multigene family

1 reference

12 December 2020

Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.

1 reference

12 December 2020

Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice

1 reference

12 December 2020

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

1 reference

12 December 2020

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

1 reference

12 December 2020

Communication between multiple drug binding sites on P-glycoprotein

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011080418027

1 reference

25 November 2017

1 reference

PubMed ID

11405289